VINC — Vincerx Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Vincerx Pharma Announces Proposed Underwritten Public Offering Of Common Stock And Warrants
U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi
U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna
U.S. STOCKS ON THE MOVE-Bloom Energy, Hecla Mining, Alkermes
U.S. STOCKS ON THE MOVE-Gold miners, Taysha Gene, American Eagle
Vincerx Pharma tumbles as cancer therapy study data comes in below expectations
Brief: Vincerx Pharma Presents Positive Preliminary Phase 1 Data For Vip236 At The American Association For Cancer Research Annual Meeting 2024
Vincerx Pharma Inc reports results for the quarter ended in December - Earnings Summary
Vincerx Pharma Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2)
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
U.S. STOCKS ON THE MOVE-Moderna, Coinbase, Ambrx Biopharma
Vincerx Pharma climbs on positive data from early-stage cancer therapy trial
Brief: Vincerx Pharma Announces Compelling Clinical Efficacy Of Enitociclib In Combination With Venetoclax And Prednisone In Lymphoma
Brief: Vincerx Pharma Says On September 14, Received Notice From Nasdaq Notifying Company Not In Compliance With Minimum Bid Price Requirement
Brief: Vincerx Pharma Doses First Patient In The Phase 1 Clinical Trial Evaluating Vip943
U.S. STOCKS ON THE MOVE-AMTD Digital, BioXcel, Hasbro
U.S. STOCKS ON THE MOVE-AppLovin, SolarEdge, Fabrinet